產(chǎn)品介紹
C9 Protein
A407
250 μL/vial
1.0 mg/mL
> 85%
PBS
At or below –70°C
Purified human complement component C9. Complement component C9 is unique to the terminal complement pathway. It is a single chain protein with a molecular weight of 69 kD and is present in plasma at approximately 60 mg/L. Together with the other proteins of the terminal pathway, C9 forms the membrane attack complex or MAC.
All Quidel complement components are tested for functional activity in a standard lytic or applicable functional assay and for biochemical purity by SDS-polyacrylamide gel electrophoresis. Please refer to the Certificate of Analysis for lot specific information on functional titer.
Nicholson-Weller, Butko, P, Wessels, M. Role of Complement Component C1q in IgG independent Opsonophagocytosis of Group B Streptococus, J. Immunol 163:2761-2768, 1999.
Koski, C., Dashell, S. Sublytic terminal complement complex decreases Po gene expression in schwan cells, J Neurochem 73(6):2321-2330, 1999.
Liu, C., et al. Interaction between the terminal complement pathway complex C5b-7 and anionic phospholipids, Blood 93(7)2291-2301, 1999.
For Research Use Only. Not for use in diagnostic procedures.
BIOLEAF熱搜 BIOLEAF試劑盒 BIOLEAF ELISA BIOLEAF試劑 BIOLEAF品牌 BIOLEAF抗體 BIOLEAF耗材 BIOLEAF小儀器
sitemap 細胞庫查詢 危險品圖標 本公司網(wǎng)站所展示銷售的產(chǎn)品僅供科研!
滬公網(wǎng)安備 31011202007338號